Promis Neurosciences Inc. (PMN) — DEF 14A Filings
All DEF 14A filings from Promis Neurosciences Inc.. Browse 4 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (4)
-
ProMIS Neurosciences Seeks Shareholder Nod for 1:5 to 1:25 Reverse Split
— Oct 3, 2025 Risk: medium
ProMIS Neurosciences Inc. (PMN) is holding a Special Meeting on November 17, 2025, to seek shareholder approval for a share consolidation (reverse stock split) -
ProMIS Neurosciences Files 2025 Proxy Statement
— Apr 29, 2025 Risk: medium
ProMIS Neurosciences Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting on June 12, 2025. The company, formerly known as Amorfi -
ProMIS Neurosciences Files Proxy Statement for Oct. 23 Meeting
— Sep 9, 2024 Risk: low
ProMIS Neurosciences Inc. filed a definitive proxy statement (DEF 14A) on September 9, 2024, for its annual meeting on October 23, 2024. The company, formerly k -
ProMIS Neurosciences Inc. Announces 2024 Annual Meeting of Shareholders
— Apr 25, 2024 Risk: low
ProMIS Neurosciences Inc. (PMN) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. The 2024 Annual Meeting of Shareholders for ProMIS Neuroscienc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX